Vaccine-Associated Leptospira Antibodies in Client-Owned Dogs Leptospira Vaccine Responses in Dogs Martin et al

BackgroundLong-term microscopic agglutination test (MAT) results after vaccination with 4-serovar Leptospira vaccines are not available for all vaccines used in client-owned dogs. Hypothesis/ObjectivesTo determine antibody responses of client-owned dogs given 1 of 4 commercially available Leptospira vaccines. AnimalsHealthy client-owned dogs (n=32) with no history of Leptospira vaccination for at least the previous year. MethodsDogs were given 1 of 4 Leptospira vaccines on week 0 and then approximately on week 3 and week 52. Sera were collected before vaccine administration on week 0 and then within 3days of week 3, within 2days of week 4, and approximately on weeks 7, 15, 29, 52, and 56. Antibody titers against Leptospira serovars bratislava, canicola, grippotyphosa, hardjo, icterohemorrhagiae, and pomona and were determined by MAT. ResultsWhen compared among vaccines, MAT results varied in maximal titers, the serovars inducing maximal titers, and the time required to reach maximal titers. Each vaccine induced at least some MAT titers 1:800. Most dogs were negative for antibodies against all serovars 1year after vaccination, and anamnestic responses were variable. Conclusions and Clinical ImportanceDogs vaccinated with Leptospira vaccines have variable MAT titers over time, and antibodies should not be used to predict resistance to Leptospira infection. MAT titers 1:800 can develop after Leptospira spp. vaccination, which can complicate the clinical diagnosis of leptospirosis.